Literature DB >> 26266139

Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates.

Deepak Passi1, Sarang Sharma2, Shubha Ranjan Dutta3, Pooja Dudeja2, Vivek Sharma4.   

Abstract

Ebola virus disease (EVD) described as "one of the world's most virulent diseases" by WHO was popularly known as Ebola haemorrhagic fever in the past. It is usually considered a severe and deadly illness when humans are concerned. EVD outbreaks have shown to have a very high fatality rate ranging from 50 - 90% with a reported occurrence primarily seen near the tropical rainforests of remote villages in Central and West Africa. The virus is transmitted to people from wild animals and within the human community through human-to-human contact. Natural host for Ebola virus is not yet conclusively identified but the most probable host appears to be the fruit bats of the Pteropodidae family. Five subspecies of Ebola virus are recognized till date, with Zaire Ebola virus being the most aggressive of all varieties and recording up to 90% mortality. All Ebola forms are highly contagious and hence have been classed as Category A Priority Pathogens by WHO. Severely ill patients warrant intensive support therapy. Medical workers working in affected areas need to undertake extensive measures to prevent contracting the disease. Till date, no particular anti-viral therapy has demonstrated effectiveness in Ebola virus infection. Also, no vaccine for use in humans is yet approved by the regulatory bodies. If Ebola was actually misused as a biological weapon, it could be a serious threat. Idea behind this article is to briefly review the history and present recent updates on Ebola virus, its pathogenesis and possible hopes for treatment.

Entities:  

Keywords:  Coagulopathy; Epidemic; Haemorrhagic fever; Zoonotic

Year:  2015        PMID: 26266139      PMCID: PMC4525528          DOI: 10.7860/JCDR/2015/13062.6100

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Authors:  Paul W H I Parren; Tom W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 2.  Ebola virus pathogenesis: implications for vaccines and therapies.

Authors:  Nancy Sullivan; Zhi-Yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; M C Georges-Courbot; M Capron; J Lansoud-Soukate; P Debré; S P Fisher-Hoch; J B McCormick; A J Georges
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

4.  Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire.

Authors:  S Pattyn; G van der Groen; W Jacob; P Piot; G Courteille
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

5.  Development of a preventive vaccine for Ebola virus infection in primates.

Authors:  N J Sullivan; A Sanchez; P E Rollin; Z Y Yang; G J Nabel
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

6.  Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo.

Authors:  Pierre Formenty; Eric Maurice Leroy; Alain Epelboin; Francois Libama; Marco Lenzi; Hinrich Sudeck; Philippe Yaba; Yokouidé Allarangar; Paul Boumandouki; Virginot Blad Nkounkou; Christian Drosten; Allen Grolla; Heinz Feldmann; Cathy Roth
Journal:  Clin Infect Dis       Date:  2006-04-26       Impact factor: 9.079

Review 7.  Clinical aspects of African viral hemorrhagic fevers.

Authors:  J H Gear
Journal:  Rev Infect Dis       Date:  1989 May-Jun

8.  Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection.

Authors:  A Baskerville; S P Fisher-Hoch; G H Neild; A B Dowsett
Journal:  J Pathol       Date:  1985-11       Impact factor: 7.996

Review 9.  Intracellular events and cell fate in filovirus infection.

Authors:  Judith Olejnik; Elena Ryabchikova; Ronald B Corley; Elke Mühlberger
Journal:  Viruses       Date:  2011-08       Impact factor: 5.048

10.  Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.

Authors:  Wendelien B Oswald; Thomas W Geisbert; Kelly J Davis; Joan B Geisbert; Nancy J Sullivan; Peter B Jahrling; Paul W H I Parren; Dennis R Burton
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

View more
  7 in total

1.  Ebola virus outbreak returns to the Democratic Republic of Congo: An urgent rising concern.

Authors:  Jeffrey Sun; Olivier Uwishema; Hadi Kassem; Mortada Abbass; Lama Uweis; Anushree Rai; Rayyan El Saleh; Irem Adanur; Helen Onyeaka
Journal:  Ann Med Surg (Lond)       Date:  2022-06-06

Review 2.  Applications of gold nanoparticles in virus detection.

Authors:  Mohamed Shehata Draz; Hadi Shafiee
Journal:  Theranostics       Date:  2018-02-15       Impact factor: 11.556

3.  Ebola Virus Uptake into Polarized Cells from the Apical Surface.

Authors:  Meng Hu; Fei Wang; Wei Li; Xiaowei Zhang; Zhiping Zhang; Xian-En Zhang; Zongqiang Cui
Journal:  Viruses       Date:  2019-12-02       Impact factor: 5.048

Review 4.  Silver nanoparticles as a potential treatment against SARS-CoV-2: A review.

Authors:  Fernanda Pilaquinga; Jeroni Morey; Marbel Torres; Rachid Seqqat; María de Las Nieves Piña
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-02-27

5.  Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus Disease.

Authors:  Arthur Viodé; Kinga K Smolen; Eleanor N Fish; Hanno Steen; Benoit Fatou; Zainab Wurie; Patrick Van Zalm; Mandy Kader Konde; Balla Moussa Keita; Richard Amento Ablam
Journal:  mBio       Date:  2022-04-21       Impact factor: 7.786

Review 6.  Silver Nanoparticles as Potential Antiviral Agents.

Authors:  Zubair Ahmed Ratan; Fazla Rabbi Mashrur; Anisha Parsub Chhoan; Sadi Md Shahriar; Mohammad Faisal Haidere; Nusrat Jahan Runa; Sunggyu Kim; Dae-Hyuk Kweon; Hassan Hosseinzadeh; Jae Youl Cho
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

Review 7.  Micro and Nanoscale Technologies for Diagnosis of Viral Infections.

Authors:  Fatemeh Nasrollahi; Reihaneh Haghniaz; Vahid Hosseini; Elham Davoodi; Mahboobeh Mahmoodi; Solmaz Karamikamkar; Mohammad Ali Darabi; Yangzhi Zhu; Junmin Lee; Sibel Emir Diltemiz; Hossein Montazerian; Sivakoti Sangabathuni; Maryam Tavafoghi; Vadim Jucaud; Wujin Sun; Han-Jun Kim; Samad Ahadian; Ali Khademhosseini
Journal:  Small       Date:  2021-07-26       Impact factor: 15.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.